One of the most basic ideas that goes along with the stock market is buy low and sell high. Although this advice is overly obvious, many new investors will do the exact opposite when trading stocks. Inexperienced investors have the tendency to buy stocks that have been performing the best recently. This may be caused by certain factors such as not looking into the underlying fundamentals or just hoping that the stock will continue to rise. Rookie investors may also make the error of holding onto shares that continue to drop in value. Instead of cutting the loser loose, they hold off with the hope that eventually the stock will at least get back to the breakeven point. 

Tracking the Hull Moving Average for Opiant Pharmaceuticals, Inc. (OTCMKTS:OPNT), we note that the current level is 14.73025. The Hull Moving Average was introduced by Alan Hull. Swing traders often use this indicator in combination with other signals in order to help identify possible entry and exit spots.

Expanding the technical focus for Opiant Pharmaceuticals, Inc. (OTCMKTS:OPNT), we see that the Keltner Channels 20 day upper band is 14.660615, and the 20 day lower band is13.374256. The Keltner Channels indicator is similar to Bollinger Bands and Moving Average Envelopes.

There are multiple moving average indicators that traders may rely on when conducting stock research. One of the most popular is the Simple Moving Average. The SMA is unweighted, meaning that each period in the set of data is weighted equally. Looking at some SMA levels, we can see that the 10 day is 13.75731, the 20 day is 13.858475, and the 30 day is 13.972763. Tracking some other time periods, we note that the 50 day SMA is 14.67142 , the 100 day is 15.56178 , and the 200 day SMA is currently 17.22664.

Many traders will look to optimize stock trades by using various technical indicators. The Ichimoku Cloud indicator is highly flexible and is commonly used in conjunction with the RSI to help confirm momentum and overall trends. Let’s focus on a few different Ichimoku readings:

Ichimoku Cloud Base Line: 13.51
Ichimoku Cloud Conversion Line: 13.9
Ichimoku Lead 1: 14.9325
Ichimoku Lead 2: 15.2

Traders focusing on technical analysis may be interested in following the Awesome Oscillator level. Currently, the reading is 0.040386178. Typically, when the Awesome Oscillator moves above the zero line, this would indicate that the short term momentum is rising quicker than the long term momentum. A cross below the zero line would indicate that short term momentum is dropping faster than the long term momentum.

Traders following shares of Opiant Pharmaceuticals, Inc. (OTCMKTS:OPNT) may have noted that the stock most recently closed at 14.8764. Going back a full-year, the stock has seen a change of -36.26221 over that stretch. Taking the focus in to more recent action, shares have seen a move of 9.304923 over the last week. Over the prior month, the stock has moved -6.7894735. Over the past three months, the stock has moved -11.660333.

Tracking some one month stock pivot points, we note that the Classic Pivot is 13.88, the Classic resistance 1 is 14.47, and the Classic support 1 is presently 12.76. The Fibonacci one month pivot is 13.88 while the Fibonacci support 1 pivot is 13.22678, and the Fibonacci support 2 is 12.82322. Looking at one month Woodie pivot, we note the level at 13.7925. The Woodie support 1 pivot is 12.585, and the Woodie resistance 1 pivot is 14.295.

Investors might be looking to find some bargains to add to the portfolio as we move closer towards the end of the year. Maybe some of the earlier portfolio picks don’t look as promising as they did a few months ago. There might also be a few names that have fallen off a cliff and do not look they will be returning to previous levels. Investors may be searching for a few overlooked stocks that the rest of the investing community has passed on for whatever reason. Nobody knows for sure what the next couple of quarters have in store. As earnings season kicks off, investors will be closely following the companies that manage to beat expectations by a wide margin.   

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.